Coronary revascularization procedures by means of percutaneous coronary interventions or
coronary artery bypass graft surgeries are performed worldwide daily for the symptomatic …

Background: In patients with native coronary artery disease, strong evidence supports the
use of statins to reduce the risk of recurrent cardiovascular events and improve survival …

Background Secondary preventive therapies play a key role in the prevention of adverse
events after coronary artery bypass grafting (CABG). However, adherence to secondary …

Trasfondo: El manejo de medicamentos de pacientes después de IDAC puede incluir
agentes anti-plaquetarios, bloqueadores beta, inhibidores de ECA, y estatinas. Sin …

OBJECTIVE: β-Blockers improve outcomes in patients with heart failure or a history of
myocardial infarction, but it remains uncertain whether they are beneficial after the …

OBJECTIVES: The benefits of statin therapy for patients with coronary artery disease have
been well documented, including those occurring after coronary artery bypass graft surgery …

Objective (i) To examine the sustainability of an in-hospital quality improvement (QI)
intervention, the American College of Cardiology's Guideline Applied to Practice (GAP) in …

Background—Eliminating out-of-pocket costs for patients after myocardial infarction (MI)
improves adherence to preventive therapies and reduces clinical events. Because …

Despite receiving complete revascularization using multiple arterial conduits, patients who
undergo coronary artery bypass grafting (CABG) are still susceptible to recurrent major …

BACKGROUND: Despite the robust evidence of the potential benefits of n-3 polyunsaturated
fatty acid (PUFA) supplementation in patients with established coronary artery disease, the …